SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-013565
Filing Date
2024-02-12
Accepted
2024-02-12 06:06:37
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245464d20_sc13ga.htm SC 13G/A 69234
  Complete submission text file 0001104659-24-013565.txt   70838
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91005 | Film No.: 24617222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

IRS No.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A